MALAT1 and lung carcinoma: In a xenograft lung cancer metastasis model, ASO blocking MALAT1 can markedly reduce metastasis [97]; thus, silencing MALAT1 may be an appropriate therapeutic target, and MALAT1 can be therapeutically targeted by ASO and siRNA.